Press release —
Sigrid Therapeutic's CEO Sana Alajmovic on International High List of Young Life Science Innovators
Stockholm, July 11, 2019. The leading American life science magazine BioSpace has named Sana Alajmovic one of 10 young life science innovators under the age of 40 to watch in the future. Sana Alajmovic is the only non-American on the list.
Earlier this year, Sana Alajmovic, CEO and co-founder of Sigrid Therapeutics, was named to the international magazine Genetic Engineering News' list of the 10 most promising leaders in business and academia under the age of 40. Now, the American magazine BioSpace has also named Sana one of 10 life science innovators under the age of 40 to watch, putting her in strong global competition with other young leaders from Stanford University, Harvard University and Yale University School of Medicine .
"I am incredibly proud and grateful for the attention this brings to Sigrid internationally and would like to take this opportunity to thank my team for the positive energy I receive and that drives me forward every day. We have an exciting time ahead of us at Sigrid as we approach the market with our first product for lowering blood sugar in people at risk of developing type 2 diabetes"
The list of BioSpace 10 Innovators Under 40 to Watch can be found here: https://www.biospace.com/article/10-life-science-innovators-under-40-to-watch/
Topics
Categories
SIGRID is a Swedish consumer health company developing technologies designed to reduce the metabolic impact of modern meals. The company’s patented SiPore® technology works locally in the gastrointestinal tract by interacting with digestive enzymes involved in carbohydrate and fat digestion. By slowing nutrient breakdown during digestion, SiPore® supports steadier post-meal metabolic responses. SIGRID collaborates with clinicians, researchers, and health innovators to translate metabolic science into practical solutions supporting metabolic health, weight management, and glucose stability. The company was founded in 2014 and is headquartered in Stockholm, Sweden.
